Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document - PubMed (original) (raw)

Guideline

Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document

S A Khan et al. Gut. 2002 Nov.

No abstract available

PubMed Disclaimer

Figures

Figure 1

Figure 1

Schematic diagram for sites of cholangiocarcinoma. Intrahepatic cholangiocarcinoma (International Classification of Disease-9 codes (ICD-9) 155.1): 1=peripheral cholangiocarcinoma; 2a, b=right and left hepatic ducts; and 3=confluence of right and left hepatic ducts (perihilar, Klatskin tumours). Extrahepatic (ICD-9 156): 4=common hepatic duct; 5=gall bladder (ICD-9 156.0); 6=cystic duct; and 7=common bile duct.

Figure 2

Figure 2

Management algorithm for cholangiocarcinoma. US, ultrasonography; MRCP, MR cholangiopancreatography; MRA, MR angiography; ERCP, endoscopic retrograde cholangiopancreatography; PTC, percutaneous transhepatic cholangiography. *Where magnetic resonance imaging/MRCP is not possible, patients should have contrast enhanced spiral/helical computed tomography. **Fine needle biopsy or biopsy is ideally avoided until resectability has been assessed by a specialist surgeon.

References

    1. Ann Surg. 1998 Jan;227(1):70-9 - PubMed
    1. Hepatology. 2001 May;33(5):1029-35 - PubMed
    1. Ann Oncol. 1998 Jun;9(6):653-6 - PubMed
    1. J Hepatobiliary Pancreat Surg. 1998;5(1):52-61 - PubMed
    1. J Am Coll Surg. 1998 Oct;187(4):358-64 - PubMed

Publication types

MeSH terms

LinkOut - more resources